CATALOGO DEI PRODOTTI DELLA RICERCA

Mariotto, Sara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.758
EU - Europa 2.295
AS - Asia 1.267
AF - Africa 34
OC - Oceania 24
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.750
CN - Cina 894
GB - Regno Unito 444
IT - Italia 344
RU - Federazione Russa 317
IE - Irlanda 290
SE - Svezia 285
FR - Francia 259
DE - Germania 176
SG - Singapore 169
FI - Finlandia 85
VN - Vietnam 61
ID - Indonesia 34
KR - Corea 29
TG - Togo 29
UA - Ucraina 29
AU - Australia 23
IR - Iran 23
BE - Belgio 21
IN - India 17
HK - Hong Kong 13
JP - Giappone 13
ES - Italia 8
NL - Olanda 7
CA - Canada 5
CL - Cile 4
LU - Lussemburgo 4
RO - Romania 4
AR - Argentina 3
BG - Bulgaria 3
BR - Brasile 3
CZ - Repubblica Ceca 3
AT - Austria 2
CH - Svizzera 2
HU - Ungheria 2
IL - Israele 2
LT - Lituania 2
TR - Turchia 2
TW - Taiwan 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 6.390
Salva come PNG Salva come JPEG
Città #
Chandler 674
Southend 403
Ashburn 287
Dublin 276
Beijing 210
Woodbridge 145
Jacksonville 127
Verona 119
Singapore 112
New York 99
Lawrence 96
Princeton 96
Ann Arbor 93
Wilmington 83
Jinan 69
Dearborn 66
Houston 55
Shenyang 54
Redmond 53
Sindelfingen 52
Nanjing 51
Helsinki 49
Hebei 43
Washington 37
Dong Ket 36
Jakarta 34
Lomé 29
Tianjin 28
Ningbo 27
Seattle 27
Seoul 27
Boardman 26
Milan 26
Adelaide 22
Hangzhou 22
Brussels 21
Changsha 21
Falls Church 21
Guangzhou 20
Nanchang 20
Bologna 19
Zhengzhou 19
Kent 18
Taiyuan 18
Haikou 17
Los Angeles 17
Chicago 16
Dallas 16
Redwood City 16
Norwalk 15
Taizhou 14
Bloomsbury 13
Fairfield 11
Hong Kong 11
Lappeenranta 11
Menlo Park 11
Dongguan 10
Jiaxing 10
Lanzhou 9
Florence 8
Hefei 8
Lancaster 8
Fuzhou 7
Tokyo 7
Valencia 7
Clearwater 6
Paris 6
San Diego 6
Udine 6
Bussolengo 5
Cambridge 5
Phoenix 5
Yicheng 5
Brescia 4
Cagliari 4
Catanzaro 4
Düsseldorf 4
Frankfurt am Main 4
Kochi 4
Moscow 4
Padova 4
Shenzhen 4
Tappahannock 4
Treviso 4
Bari 3
Buenos Aires 3
Carpi 3
Edinburgh 3
Fort Worth 3
Göttingen 3
Hyderabad 3
Riva 3
San Francisco 3
Sant'Ambrogio di Valpolicella 3
Santa Clara 3
Shanghai 3
Sofia 3
Ardabil 2
Bochum 2
Büdelsdorf 2
Totale 4.205
Salva come PNG Salva come JPEG
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 140
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 123
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 123
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 115
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 113
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 105
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 105
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 103
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 99
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 98
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 95
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 93
HCV-related nervous system disorders. 92
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 92
Brentuximab vedotin: axonal microtubule's Apollyon 85
l-dopa-induced off: functional overlay in Parkinson disease 83
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 81
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 81
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 80
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 79
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 79
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 77
Cerebrospinal fluid analysis and the determination of oligoclonal bands 74
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 73
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 72
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 72
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 72
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 72
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 71
Infectious neuropathies 70
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 69
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 69
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 69
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 68
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 67
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 66
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 65
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 64
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 64
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 63
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 63
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 63
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 62
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 62
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 61
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 60
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 60
Gender disparity in editorial boards of journals in neurology 60
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 59
Inter-center agreement in the interpretation of oligoclonal bands 59
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 58
Nervous system: subclinical target of SARS-CoV-2 infection 57
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 57
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 56
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 56
Diagnostics of dysimmune peripheral neuropathies 55
HCV-related central and peripheral nervous system demyelinating disorders. 53
Lymphomatosis cerebri and anti-NMDAR antibodies: A unique constellation 53
Autoimmune encephalitis: a retrospective monocentric experience 53
Diagnostics of paraneoplastic neurological syndromes 52
Exposure to TNF inhibitors is rare at MOGAD presentation 52
Oligoclonal bands: clinical utility and interpretation cues 52
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 52
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 51
Diagnostics of anti-MAG antibody polyneuropathy 50
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 50
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 49
Distinct serum and cerebrospinal fluid cytokine and chemokine profiles in autoantibody-associated demyelinating diseases 49
Anti-MOG-associated demyelinating disorders: two sides of the same coin 48
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 48
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 47
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 46
Superior diagnostic performance of reduced-FOV DWI versus conventional DWI MRI in anti-NMDAR encephalitis 45
HCV RNA genomic sequences and HCV-E2 glycoprotein in sural nerve biopsies from hcv-infected patients with peripheral neuropathy 44
Serum neurofilament light chain studies in neurological disorders, hints for interpretation 44
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 44
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 44
Ophthalmoparesis mimicking myasthenia gravis as acute manifestation of Hashimoto’s encephalopathy 42
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 42
Serum neurofilament light chain levels as biomarker of paclitaxel-induced cognitive impairment in patients with breast cancer: a prospective study 42
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 41
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 38
Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma 36
Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers 35
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 35
Peripheral neuropathy and central nervous system involvement in cryoglobulinemia 34
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 34
Is there a correlation between MOGAD and SARS-CoV-2 infection? 34
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 33
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 33
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 31
GAD65 autoimmunity after treatment with nivolumab: a multifocal presentation 31
Differential binding of autoantibodies to MOG isoforms in inflammatory demyelinating diseases 31
Treatment options in refractory autoimmune encephalitis 29
Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders 29
COVID-19 impact on consecutive neurological patients admitted to the emergency department 29
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 28
Treatment of myelin oligodendrocyte glycoprotein antibody associated disease with subcutaneous immune globulin 28
Autoimmune encephalitis misdiagnosis and mimics 26
More efficient complement activation by Anti-Aquaporin-4 compared with Anti-Myelin Oligodendrocyte Glycoprotein antibodies 25
Totale 6.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.991
article - articoli 28.324
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 239
patent - brevetti 0
selected - selezionate 0
volume - volumi 428
Totale 57.982
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020516 0 0 0 16 105 54 121 14 28 67 39 72
2020/2021679 124 74 32 81 67 61 27 17 45 9 73 69
2021/2022839 54 260 2 114 19 32 14 36 31 37 70 170
2022/20231.896 112 186 156 334 141 458 23 129 225 33 61 38
2023/20241.257 47 79 135 135 109 299 55 76 20 68 166 68
2024/2025680 147 196 118 219 0 0 0 0 0 0 0 0
Totale 6.632